Literature DB >> 18040766

Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region.

Xiaomin Zhao1, Stefan Schwartz.   

Abstract

The human papillomavirus type 16 (HPV-16) L1 capsid protein is very poorly expressed from cDNA expression plasmids transiently transfected into mammalian cells. The results described herein demonstrate that inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of splicing regulatory sequences in the L1 coding region. This inhibitory effect correlates with the binding of hnRNP A1 to the RNA elements. Similar to unutilised splice sites that may retain mRNAs in the nucleus, regulatory splicing RNA elements may also inhibit gene expression in the absence of splicing. The results presented here explain the inefficient expression of HPV-16 L1 protein from the wild type L1 cDNA expression plasmids in mammalian cells. These results may be of general interest since alteration of RNA sequences to prevent unwanted RNA-protein interactions may increase expression of many different genes in transient transfections or after plasmid uptake in DNA vaccination approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040766     DOI: 10.1007/s11262-007-0174-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  38 in total

1.  Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family.

Authors:  M Caputi; A M Zahler
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

2.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

3.  Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs.

Authors:  Ichiro Taniguchi; Kaoru Masuyama; Mutsuhito Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

Review 4.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

5.  A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

Authors:  Daniel Oberg; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.

Authors:  C Leder; J A Kleinschmidt; C Wiethe; M Müller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  mRNA instability elements in the human papillomavirus type 16 L2 coding region.

Authors:  M Sokolowski; W Tan; M Jellne; S Schwartz
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

9.  Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV).

Authors:  W Zhou; R F Cook; S J Cook; S A Hammond; K Rushlow; N N Ghabrial; S L Berger; R C Montelaro; C J Issel
Journal:  Vet Microbiol       Date:  2002-08-25       Impact factor: 3.293

10.  PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression.

Authors:  Andrei S Zolotukhin; Daniel Michalowski; Jenifer Bear; Sergey V Smulevitch; Abdulmaged M Traish; Rui Peng; James Patton; Ivan N Shatsky; Barbara K Felber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more
  13 in total

1.  Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.

Authors:  Soniya Dhanjal; Naoko Kajitani; Jacob Glahder; Ann-Kristin Mossberg; Cecilia Johansson; Stefan Schwartz
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 2.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 3.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

Review 4.  RNA Binding Proteins that Control Human Papillomavirus Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Biomolecules       Date:  2015-05-05

5.  Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.

Authors:  Xiaoze Li; Cecilia Johansson; Jacob Glahder; Ann-Kristin Mossberg; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2013-09-05       Impact factor: 16.971

Review 6.  Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.

Authors:  Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2017-02-09       Impact factor: 5.923

Review 7.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

8.  hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.

Authors:  Naoko Kajitani; Jacob Glahder; Chengjun Wu; Haoran Yu; Kersti Nilsson; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 9.  hnRNP A1: the Swiss army knife of gene expression.

Authors:  Jacques Jean-Philippe; Sean Paz; Massimo Caputi
Journal:  Int J Mol Sci       Date:  2013-09-16       Impact factor: 5.923

10.  Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.

Authors:  Xiaoze Li; Cecilia Johansson; Carlos Cardoso Palacios; Anki Mossberg; Soniya Dhanjal; Monika Bergvall; Stefan Schwartz
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.